rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2000-1-24
|
pubmed:abstractText |
To test the clinical response of systemic lupus erythematosus (SLE) patients to intravenous immunoglobulins (IVIg), and whether the clinical response of IVIg treatment in SLE is accompanied by modification of SLE-associated autoantibodies/antibodies (Abs) and complement levels.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0961-2033
|
pubmed:author |
pubmed-author:AhmedAA,
pubmed-author:FabbrizziFF,
pubmed-author:GeorgeJJ,
pubmed-author:LangevitzPP,
pubmed-author:LeviII,
pubmed-author:LorberMM,
pubmed-author:MeissnerMM,
pubmed-author:PeterJ BJB,
pubmed-author:ShererYY,
pubmed-author:ShoenfeldYY,
pubmed-author:TerryberryJJ
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
705-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10602441-Adult,
pubmed-meshheading:10602441-Antibody Specificity,
pubmed-meshheading:10602441-Autoantibodies,
pubmed-meshheading:10602441-Female,
pubmed-meshheading:10602441-Humans,
pubmed-meshheading:10602441-Immunoglobulins, Intravenous,
pubmed-meshheading:10602441-Lupus Erythematosus, Systemic,
pubmed-meshheading:10602441-Male,
pubmed-meshheading:10602441-Middle Aged,
pubmed-meshheading:10602441-Predictive Value of Tests,
pubmed-meshheading:10602441-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
|
pubmed:affiliation |
Department of Medicine 'B' and the Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|